Methylergonovine Maleate



Methylergonovine Maleate





(meth ill er goe noe’ veen)

Methergine (CAN)

PREGNANCY CATEGORY C


Drug Classes

Ergot derivative

Oxytocic


Therapeutic Actions

A partial agonist or antagonist at alpha receptors; as a result, it increases the strength, duration, and frequency of uterine contractions, which shortens the third stage of labor and reduces blood loss.


Indications



  • Routine management after delivery of the placenta


  • Treatment of postpartum atony and hemorrhage; subinvolution of the uterus


  • Uterine stimulation during the second stage of labor following the delivery of the anterior shoulder, under strict medical supervision



Available Forms

Tablets—0.2 mg; injection—0.2 mg/mL


Dosages

Adults

IM

0.2 mg IM after delivery of the placenta, after delivery of the anterior shoulder, or during puerperium. May be repeated every 2–4 hr.

IV

Same dosage as IM; infuse slowly IV over at least 60 sec. Monitor BP very carefully as severe hypertensive reaction can occur; reserve this route for emergency situations.

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Jul 21, 2016 | Posted by in NURSING | Comments Off on Methylergonovine Maleate

Full access? Get Clinical Tree

Get Clinical Tree app for offline access